Sa1884 Infliximab Versus Immunomodulator as First Maintenance Therapy in Children With Crohn Disease
Document Type
Article
Publication Date
5-2012
Repository Citation
Markowitz, J.,
Evans, J.,
Pfefferkorn, M.,
Griffiths, A.,
Keljo, D.,
Mack, D. R.,
Carvalho, R.,
Leleiko, N.,
Otley, A.,
Rosh, J.,
Stephens, M.,
Saeed, S. A.,
Ashai-Khan, F. N.,
Bousvaros, A.,
Kay, M. H.,
Oliva-Hemker, M.,
Grossman, A.,
Sudel, B.,
Kappelman, M.,
Dimmitt, R.,
Langton, C. R.,
& Hyams, J. S.
(2012). Sa1884 Infliximab Versus Immunomodulator as First Maintenance Therapy in Children With Crohn Disease. Gastroenterology, 142 (5), Supplement 1:S.
https://corescholar.libraries.wright.edu/pediatrics/600
DOI
10.1016/S0016-5085(12)61319-5
